• Advocacy News

     
     
     
    Type Size
     

    Hart Health Strategies Health Policy Briefing

    September 30, 2019

    SCAI shares the weekly Health Policy Briefing update. This week Hart Health Strategies reports that the Senate passed a stopgap spending measure (H.R. 4378) to prevent a government shutdown. The continuing resolution (CR) would fund the government until November 21. The package includes the bipartisan Fair and Accurate Medicaid Pricing (AMP) Act (H.R. 3276). This bill would repeal the requirement that drug manufacturers include the prices of certain authorized generics when calculating the average manufacturer price (AMP) of brand drugs and would exclude manufacturers from the definition of wholesalers in the calculation of Medicaid drug rebates. Estimates indicate that such changes will produce savings of $3.1 billion over the next decade. To learn more.